Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Operating Leases: 2022-2023

Historic Operating Leases for Therapeutics (RAPT) over the last 2 years, with Dec 2023 value amounting to $4.5 million.

  • Therapeutics' Operating Leases fell 48.80% to $2.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.6 million, marking a year-over-year decrease of 48.80%. This contributed to the annual value of $4.5 million for FY2023, which is 34.62% down from last year.
  • Therapeutics' Operating Leases amounted to $4.5 million in FY2023, which was down 34.62% from $6.8 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Operating Leases registered a high of $6.8 million during FY2022, and its lowest value of $4.5 million during FY2023.
  • Its 2-year average for Operating Leases is $5.6 million, with a median of $5.6 million in 2022.
  • Data for Therapeutics' Operating Leases shows a maximum YoY crashed of 34.62% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Operating Leases (Yearly) stood at $6.8 million in 2022, then crashed by 34.62% to $4.5 million in 2023.